Heart Outcomes Prevention Evaluation Study Investigators. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med 2000;342:145-53.

By S. Yusuf, P. Jha. 2000

1,047 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019) (2019, background): “prevented coronary artery disease, reducing coronary plaque [724, 892, 939, 941].”